| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.3 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.3 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.032 | 0.3 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | -0.03 | 0.3 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | Tipifarnib | FIMM | pan-cancer | AAC | 0.13 | 0.3 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |